PNV 0.38% $2.64 polynovo limited

Ann: NovoSorb MTX First Sales and March 2023 $6m Revenue, page-134

  1. 5,270 Posts.
    lightbulb Created with Sketch. 244
    Even at only 50% a year in three years the company ought to be knocking on the door of $200 million annually. I don’t happen to think that year over year growth will remain this low as acceptance of BTM and now MTX continues to grow and gather momentum.

    Beyond that, no one should think that the company will go to sleep on R&D and new product families.

    The current share price is absurd, and blaming it on the “market” ignores the real culprit. As everyone knows, the market is an ass. I only wish I could find where this truism comes from, but nevertheless, it’s on the money.
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.